Melasma yana daya daga cikin matsalolin da ke damun pigment da asibitoci ke bi da su. Yana dawowa bayan laser, yana haskakawa da rana da hormones, kuma sau da yawa ya kasa amsawa ga hydroquinone kadai. Shi ya sa allurar tranexamic acid don fatar fata da sarrafa melasma ta ƙaura daga wata dabarar fasaha zuwa daidaitaccen buƙatu a ayyukan ƙayatarwa a faɗin Asiya, Gabas ta Tsakiya da Turai. Wannan jagorar ya ƙunshi yadda tranexamic acid (TXA) ke aiki akan pigment, abin da bayanan asibiti da aka buga a zahiri ke nunawa, yadda masu yin aikin yawanci ke tafiyar da ka'idar mesotherapy ta TXA, da kuma waɗanne masu rarrabawa da samfuran asibiti yakamata su duba kafin su sami dabarar TXA.
Menene Tranexamic Acid kuma Me yasa Ake Amfani da shi akan fata?
Tranexamic acid wani abu ne na roba na amino acid lysine. An fara haɓaka shi azaman maganin antifibrinolytic, ma'ana yana rage zubar jini ta hanyar toshe jujjuyawar plasminogen zuwa plasmin. Masana ilimin fata sun fara sha'awar shi bayan masu bincike sun lura cewa toshe hanyar plasminogen-plasmin kuma ya rage tasirin ultraviolet.
A cikin maganin ado, yanzu ana amfani da TXA a cikin manyan nau'i uku:
Topical serums da creams, yawanci a ƙananan yawa
Allunan na baka , waɗanda likitoci suka tsara don juriya na melasma
Intradermal microinjection (mesotherapy) , inda aka sanya maganin dilute kai tsaye a cikin yanki mai launi.
Melasma ba wai kawai 'melanin da yawa' ba ne. Ya ƙunshi tattaunawa tsakanin nau'ikan tantanin halitta da yawa a cikin fata. Anan shine sauƙaƙan sigar yadda TXA ke katse shi.
Toshe siginar plasmin
Lokacin da fata ta fallasa zuwa hasken UV, keratinocytes suna samar da ƙarin plasminogen activator. Daga nan sai Plasmin ya fitar da kwayoyin sigina irin su arachidonic acid da prostaglandins, wadanda ke tura melanocytes don samar da karin melanin. TXA yana toshe kunna plasminogen, don haka siginar motsa jiki ya raunana a tushen sa.
Nuna bangaren jijiyoyin jini
Raunin Melasma sau da yawa yana nuna ƙananan jini fiye da fata da ke kewaye, kuma abubuwan haɓakar jijiyoyin jini suna bayyana don ciyar da zagayowar launi. Saboda TXA kuma yana aiki akan hanyar plasmin da ke cikin angiogenesis, yana iya taimakawa tare da ja-launin ruwan kasa, kallon jijiyoyin jini na wasu facin melasma. Wannan shine dalili guda daya da TXA ke nuna hali daban da masu hana tyrosinase masu tsabta.
Me yasa wannan ya shafi zaɓin magani
Sinadaran irin su glutathione, bitamin C, kojic acid da arbutin galibi suna aiki akan haɗin melanin kanta. TXA yana aiki a sama, akan siginar da ke jawo shi. Wannan ya sa ya zama abokin tarayya mai ma'ana maimakon maye gurbin. Idan kuna son daki-daki akan gefen antioxidant, labarinmu akan glutathione da alluran farar fata na bayyana yadda glutathione ke tasiri pigment. Sauran wannan jagorar yana tare da TXA da melasma.
Abin da Shaidar Clinical ta Nuna
An yi nazarin microinjection TXA a cikin gwaje-gwajen da aka yi bitar takwarorinsu, kodayake yawancin ƙanana ne kuma buɗaɗɗen lakabin. Nazari guda biyu da aka ambata akai-akai suna ba da hoto na gaske:
Lee et al., Surgery Dermatologic (2006). A cikin budaddiyar gwajin gwaji na mako 12 na matan Koriya 100 da ke fama da cutar sankarau, 0.05 ml na TXA (4 mg/mL) an yi musu allurar a cikin tazara na 1 cm sau ɗaya a mako. Marasa lafiya tamanin da biyar sun kammala binciken. Ma'anar Yankin Melasma da Ma'anar Tsanani (MASI) ya faɗi daga 13.22 a asali zuwa 7.57 a mako na 12, kuma an kwatanta tasirin sakamako a matsayin ƙananan.
Budamakuntla et al., Journal of Cutaneous and Aesthetic Surgery (2013). An bazu marasa lafiya sittin zuwa ƙananan ƙwayoyin cuta na TXA ko TXA da aka kawo tare da microneedling, tare da zama uku na wata-wata. MASI ya inganta da 35.72% a cikin ƙungiyar microinjection da 44.41% a cikin ƙungiyar microneedling, ba tare da wasu manyan abubuwan da suka faru ba da aka ruwaito.
Abin da waɗannan binciken ke ba da shawara:
TXA mesotherapy na iya haifar da raguwa mai ma'ana a cikin tsananin melasma sama da makonni 8-12.
Sakamako sun bambanta. A cikin binciken Lee, yawancin marasa lafiya sun ƙididdige haɓakarsu a matsayin 'daidaitacce' (26-50% walƙiya) maimakon cikakken sharewa.
Hanyar isarwa yana da mahimmanci, kuma haɗe tare da microneedling na iya inganta shigar ciki.
Babu wani binciken da ya tabbatar da wanzuwar izini. Melasma yanayi ne na yau da kullun, don haka ya kamata asibitoci su gabatar da TXA a matsayin kayan sarrafawa da kulawa, ba magani ba.
Tsarin TXA Mesotherapy Na Musamman
Ka'idoji sun bambanta tsakanin masu sana'a da samfura, kuma kowane shirin magani yakamata ya bi umarnin samfurin don amfani da ƙa'idodin likita na gida. Tsarin gaba ɗaya da ake amfani da shi a asibitoci yayi kama da wannan.
Zaɓin haƙuri da shiri
Tabbatar da ganewar asali. Melasma, post-mai kumburi hyperpigmentation da hasken rana lentigines amsa daban-daban.
Allon don contraindications. TXA yana rinjayar hanyoyin ƙwanƙwasa, don haka tarihin thromboembolism, cututtuka na ƙumburi, maganin rigakafi ko ciki yana kira don nazarin likita kafin magani.
Ɗauki hoto a ƙarƙashin daidaitaccen haske, kuma saka shi tare da MASI ko ma'auni makamancin haka don bin haƙiƙa.
A wanke fata kuma a yi amfani da maganin kashe kwayoyin cuta idan an buƙata.
Fasahar allura
Zurfin: wuri na intradermal na waje, kusan 0.5-1 mm.
Tazara da girma: ƙananan aliquots sun bazu ko'ina cikin rauni. Ka'idojin da aka buga sunyi amfani da kusan 0.05 ml a kowace aya a tazara 1 cm.
Kayan aikin bayarwa: sirinji na insulin, gun meso, ko alkalami da abin nadi, ya danganta da ƙirar samfur da zaɓin asibiti.
Mitar zama
Nazarin da aka buga sunyi amfani da zaman mako-mako (Lee 2006) ko zaman kowane wata (Budamakuntla 2013). Yawancin hanyoyin maganin mesotherapy na TXA na kasuwanci suna ba da shawarar zama ɗaya kowane mako biyu. Kwas ɗin yawanci yana gudanar da zaman 4-8, sannan kuma jiyya na kulawa kamar yadda ake buƙata.
Bayan kulawa
Matsakaicin kariyar rana mai faɗin bakan kowace rana. Idan ba tare da shi ba, duk wani ci gaba zai shuɗe.
Kauce wa zafi, saunas da aiki mai ƙarfi na awanni 24-48.
Yi tsammanin ja mai laushi mai laushi, ƙwanƙwasawa ko ƙananan kusoshi waɗanda yawanci ke daidaita cikin kwana ɗaya ko biyu.
Haɗa TXA Tare da Sauran Ayyukan Haskakawa
Tsarin TXA na sama yana haɗe da kyau tare da sinadaran da ke ƙara yin aiki a kan hanyar melanin. Kayayyakin zamani galibi suna haɗa TXA tare da:
Glutathione da bitamin C don tallafin antioxidant da hana tyrosinase
Kojic acid, arbutin ko glycolic acid don tallafawa ko da sautin murya da juyawar tantanin halitta
PDRN (polydeoxyribonucleotide) don tallafawa gyaran fata da dawo da shinge, wanda ke da mahimmanci ga fatar melasma da ta lalace.
Intradermal TXA yana da ingantaccen rikodin aminci a cikin binciken da aka buga, amma amfani da alhakin har yanzu ya dogara da samfur da mai aiki.
Rashin haihuwa da sarrafa pyrogen ba za a iya sasantawa ba ga kowane allura. Samfuran da ba su da kyau sun kasance babban haɗari na gaske fiye da abin da ke aiki da kansa.
Halayen gida kamar erythema, ƙonewa, ɓarna da kumburin ɗan lokaci sune mafi yawan sakamakon da aka ruwaito.
haɗarin tsarin gabaɗaya don TXA na baka, wanda ya kai matakan jini mafi girma. Ana tattauna Nuna don haɗarin zubar jini har yanzu kyakkyawan aiki ne kafin allura.
Matsayin tsari ya bambanta da ƙasa. A cikin kasuwanni da yawa, ana siyar da maganin mesotherapy na TXA azaman kayan kwalliya ko kayan aikin likitanci maimakon a matsayin magunguna. Ya kamata asibitoci su duba dokokin gida kafin amfani.
Sourcing TXA Mesotherapy Solutions: Jerin Lissafi don Masu Rarraba da Alamomin Asibiti
Bukatar samfuran TXA tana da ƙarfi a kasuwanni masu yawan adadin melasma, gami da kudu maso gabashin Asiya, Gabas ta Tsakiya, Latin Amurka da sassan Turai. Idan kuna shirin shigo da ko sanya alamar sirri ga dabarar TXA, duba:
Tsare-tsare na tsari: cikakken jerin abubuwan sinadarai tare da ƙididdiga masu yawa, ba kawai 'TXA complex' ba.
Matsayin masana'anta: ISO 13485 da GMP mai dacewa da samarwa, tare da bayanan tsari.
Takaddun shaida: takardar shaidar bincike (COA), rashin haihuwa da rahotannin gwajin endotoxin, da kwanciyar hankali da bayanan rayuwa ga kowane tsari.
Zaɓuɓɓukan marufi: Girman vial, adadin akwatin da lakabi waɗanda suka dace da buƙatun rajistar kasuwar da kuke nema.
Keɓancewa: ko masana'anta na iya daidaita haɗakar aiki, misali TXA tare da PDRN da TXA tare da glutathione, don matsayin ku.
AOMA tana goyan bayan masu rarrabawa da samfuran asibiti tare da ƙira, cikawa da marufi masu zaman kansu. Ƙara koyo game da mu al'ada mesotherapy OEM mafita.
FAQ
Shin allurar tranexamic acid tana da tasiri ga fatar fata?
An fi siffanta TXA a matsayin sinadari mai sarrafa launi maimakon wakili na 'farar fata'. Nazarin asibiti ya nuna yana iya rage zafin melasma har ma da sautin sauti, amma ba ya canza launin fatar mutum.
Yaya yawancin zaman TXA mesotherapy ake buƙata don melasma?
Yawancin darussa sun ƙunshi zaman 4-8 wanda aka raba tsakanin makonni ɗaya zuwa huɗu, ya danganta da ƙa'idar da samfur. Haɓakawa mai gani a cikin binciken da aka buga ya bayyana a kusan makonni 8-12.
Shin TXA mesotherapy ya fi tranexamic acid na baka?
Suna hidima daban-daban dalilai. Oral TXA magani ne na sayan magani tare da tasirin tsari kuma yana buƙatar kulawar likita. Intradermal TXA yana ba da ƙaramin kashi na gida kai tsaye zuwa rauni. Likitan fata zai iya haɗa duka biyu don lokuta masu juriya.
Shin melasma zata iya dawowa bayan maganin TXA?
Ee. Melasma ba ta daɗe kuma tana haifar da hasken UV, zafi da hormones. Ana buƙatar kariyar rana ta yau da kullun da zaman kulawa na lokaci-lokaci don kiyaye sakamako.
Za a iya haɗa TXA da Laser ko bawo?
Yawancin ma'aikata suna amfani da TXA tare da bawo mai laushi ko laser mai ƙarancin kuzari. ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararru ta tsara su yadda ya kamata a keɓance jiyya yadda ya kamata don guje wa bacin rai da sake dawo da launi.
Bayani: Lee JH, Park JG, Lim SH, et al. Microinjection intradermal microinjection na tranexamic acid don maganin ciwon huhu a cikin majinyatan Asiya: gwajin asibiti na farko. Dermatol Surg. 2006;32 (5):626–631. Budamakuntla L, Loganathan E, Suresh DH, et al. Bazuwar, lakabin buɗaɗɗe, kwatancen nazarin microinjections na tranexamic acid da tranexamic acid tare da microneedling a cikin marasa lafiya masu fama da cutar sankara. J Cutan Aesthet Surg. 2013; 6 (3): 139–143.
Wannan labarin don bayanin ƙwararru ne kawai kuma ba shawarar likita ba ne. Ya kamata ƙwararrun likitoci su yi jiyya daidai da ƙa'idodin gida.
Dr. Emily Carter (MD, Fellow of the American Academy of Dermatology) likita ne mai ilimin kwaskwarima a birnin New York tare da fiye da shekaru 9 na gwaninta na musamman a cikin magungunan hyaluronic acid, maganin kuraje, da kuma gyaran fuska kadan. An san ta musamman don ƙwarewarta a cikin manyan hanyoyin maganin allura waɗanda ke haskaka kurajen fuska yadda ya kamata, inganta warkar da fata, da dawo da santsi ta hanyar allurar gyaran fata da aka yi niyya da dabarun haɓaka fata.
